Skip to main content

FDA recall, , High risk

Olympus High Flow Insufflation Unit

The Olympus High Flow Insufflation Unit has a software issue that may lead to overpressure events.

What happened

Olympus Corporation of the Americas, based in Center Valley, Pennsylvania, began a recall on January 16, 2026, for its Olympus High Flow Insufflation Units due to a software algorithm issue that may lead to overpressure events.

The recall, added to the FDA's Enforcement Report on February 18, 2026, covers nationwide distribution of the UHI-3, UHI-2, and UHI models, which are used for insufflation of the abdominal cavity and automatic suction and smoke evacuation to facilitate laparoscopic observation and treatment within the abdominal cavity.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the model number and UDI-DI listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Olympus High Flow Insufflation Unit.

    Model
    • UHI-3
    UDI-DI
    • 04953170140280
    • 04953170140297
    Lot code
    All Serial Numbers.

Recall details

Company began the recall
Sold in

Nationwide distribution

Company
Olympus Corporation of the AmericasCenter Valley, Pennsylvania
Risk

High risk

There is a reasonable chance that using it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
98243
Recall numbers
Z-1352-2026 to Z-1354-2026

All recalls from Olympus Corporation of the Americas

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)